Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism ALDH1A1 inhibitors(aldehyde dehydrogenase 1 family member A1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H28FN5O3S |
InChIKeyXMNLWOQHMQRHDV-UHFFFAOYSA-N |
CAS Registry2231079-74-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ovarian Cancer | Preclinical | US | 31 May 2018 |